Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin 1 pseudogene 3 (NPM1P3) is a processed pseudogene related to the functional NPM1 gene, which encodes nucleophosmin, a multifunctional nucleolar protein involved in ribosome biogenesis, cell cycle regulation, and genomic stability[1][3][5][7]. As a pseudogene, NPM1P3 does not encode a functional protein and is not implicated as a therapeutic target, biomarker, or disease modulator. Information on NPM1P3 is scarce, as research and clinical interest are centered on the functional NPM1 gene and its variants, which play well-defined roles in cancer biology, especially acute myeloid leukemia[6]. There is no established role for NPM1P3 in normal or disease biology, drug interactions, or as a therapeutic biomarker. NPM1P3 is not a protein-coding gene and therefore not a receptor, enzyme, transporter, or other classical drug target type. The designation “pseudogene” means it is a nonfunctional segment of DNA resembling the NPM1 gene, likely arising from gene duplication or retrotransposition. The main target of biomedical interest is the functional NPM1 gene (Nucleophosmin 1)[1][3][5][6][7]. There is no evidence in the literature that NPM1P3 is involved in disease or targeted by drugs. Nucleophosmin 1 pseudogene 3 (NPM1P3) is a nonfunctional genetic element and not considered a molecular target in drug discovery or biomedical research. There is nothing inherently therapeutic or actionable about this entity; if a functional or disease-related NPM1 target is intended, information about the NPM1 gene/protein should be sought instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophosmin 1 pseudogene 3 (NPM1P3).